股票 › RMD
瑞思迈 RMD
$235.30 −$4.01 (-1.68%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $235.30 0.00%
开盘$234.00
昨收$239.31
当日区间$231.95 – $236.67
成交量1.72M
市值$33.10B
市盈率（TTM）21.4
股息率1.05%
RMD 相关新闻
匹配 ResMed 或代码 RMD 的头条新闻，按最新排序。
- Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD) Gets a Buy From Canaccord Genuity
- Stifel Maintains ResMed(RMD.US) With Hold Rating
- Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD) Gets a Hold From Citi
- Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like. -- Barrons.com 正面
- RBC Capital Upgrades ResMed(RMD.US) to Buy Rating, Raises Target Price to $262 正面
- Citi Maintains ResMed(RMD.US) With Hold Rating, Raises Target Price to $240 正面
- Citi Sticks to Their Hold Rating for Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
- 8-K: Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026
- KeyBanc Maintains ResMed(RMD.US) With Buy Rating, Raises Target Price to $267 正面
- ResMed Inc: LR 1.15.3 Compliance
- Rothschild & Co Redburn Initiates ResMed(RMD.US) With Hold Rating, Announces Target Price $230
- J.P. Morgan Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
- Jarden Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
- Mizuho Securities Maintains ResMed(RMD.US) With Buy Rating, Raises Target Price to $235 正面
- Ord Minnett Remains a Buy on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
暂无评论——快来第一个聊聊 RMD。